LEGISLATIVE BUDGET BOARD

Austin, Texas

FISCAL NOTE, 81ST LEGISLATIVE REGULAR SESSION

April 24, 2009

TO:	Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health
FROM:	John S. O'Brien, Director, Legislative Budget Board
IN RE:	SB1127 by Van de Putte (Relating to the confidentiality of test results of samples of compounded products.), As Engrossed

No significant fiscal implication to the State is anticipated.

The bill would establish various provisions regarding the testing of compounded pharmaceutical products and confidentiality guidelines to be maintained by the Texas Board of Pharmacy. The bill would authorize the Board of Pharmacy to require a pharmacy to recall a compounded product and to release the results of the sample tests under certain circumstances.

The Board of Pharmacy would be required to adopt rules to align existing rules with the provisions of the bill. The Board of Pharmacy indicates duties and responsibilities associated with implementing the provisions of the bill could be accomplished by utilizing existing resources.

Local Government Impact

No fiscal implication to units of local government is anticipated.

Source Agencies:

515 Board of Pharmacy

LBB Staff:

JOB, CL, ES